Simple question re electronic requesting of Covid related analyses from primary care. Or indeed from secondary care to tertiary services like PHE.
What data / intelligence is being captured from the requestor and how is that being used/incorporated into what is being reported back electronically (retired recently. but have a real interest in these matters, and maybe on my way back to active service)
How are the EDI suppliers handling this in the absence of SNOMED specific CT terms?
So a few scenarios spring to mind:
? Diagnosis So for example sample type (swab) request basis (active Covid 19 infection) assay anticipated (RT PCR) ? how result reported
?Diagnosis, sample type (serum) assay anticipated (serological large analyser platform, or POCT) how result reported (IgM recent onset, IgG end stage infection, equivocal result (retest) or negative)
?Immunity. Sample type (serum), previous diagnosis confirmed (serological, POCT) time period since symptomatic. ?Assay unavailable (patient agrees to have sample analysed when available and used for further research) Consent form attached
How is all this data being trapped by electronic data interchange, if at all or is everything just being trapped as free text at themoment?
Thinking of all you great lab staff at this time.
All my very best wishes
Please be patient with me Jonathan :P)
John
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual who posts and they are solely responsible for all message content. The ACB does not monitor posts.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|